Opening for a new type of drug for Alzheimer’s disease
A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau. This is the finding of new research
A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau. This is the finding of new research
Years before tau tangles show up in brain scans of patients with Alzheimer’s disease, a biomarker test can detect small amounts of the clumping-prone tau
A research team has discovered that the two key pathological hallmarks of Alzheimer’s — tau protein and beta-amyloid — affect brain circuits in distinct yet
The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the
New research has shown that diet could influence the risk of both depression and Alzheimer’s disease (AD). Evidence suggests that depressive symptoms are both a